Maxim Group analyst Anthony Vendetti downgrades Pulse Biosciences (NASDAQ:PLSE) from Buy to Hold.
Maxim Group Downgrades Pulse Biosciences to Hold
Maxim Group analyst Anthony Vendetti downgrades Pulse Biosciences (NASDAQ:PLSE) from Buy to Hold.
Related Posts
EPOW Announces Revenue Growth Of 1,718% For First 3 Months Of 2023, Chairman Purchases 20,000 Shares Of Stock At An Average Price Of $2.78; Q1 2023 Revenue $8M Vs $440,000 YoY
April 14, 9:47 AM
Sunrise New Energy Co., Ltd. ("Sunrise", the "Company", "we" or "our") (NASDAQ:EPOW), today announced that the revenues for the first 3 months of 2023, ending March 31st,
Infinera Expects Preliminary 4Q23 Revenue And Net Income Per Diluted Share To Be Within Or Exceed The Previously Provided Ranges Of $421M-$451M ($436.88M Est.) And $0.05-$0.13 ($0.09 Est.)
January 11, 2:41 AM
The Company now believes
Its preliminary revenue and preliminary net income per diluted share for the third quarter of 2023 will be within or exceed the ranges provided on November 8, 2023.
Its preliminary